UnitedHealth Group Incorporated $UNH Shares Sold by Town & Country Bank & Trust CO dba First Bankers Trust CO

Town & Country Bank & Trust CO dba First Bankers Trust CO reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 56.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,225 shares of the healthcare conglomerate’s stock after selling 6,745 shares during the quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in UnitedHealth Group were worth $1,804,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. North Capital Inc. grew its position in shares of UnitedHealth Group by 16.2% during the third quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate’s stock worth $67,000 after acquiring an additional 27 shares during the last quarter. Sunflower Bank N.A. boosted its stake in UnitedHealth Group by 1.5% during the 3rd quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate’s stock valued at $662,000 after purchasing an additional 28 shares in the last quarter. Axis Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 1.7% in the 3rd quarter. Axis Wealth Partners LLC now owns 1,631 shares of the healthcare conglomerate’s stock worth $563,000 after purchasing an additional 28 shares during the last quarter. Abound Wealth Management raised its position in shares of UnitedHealth Group by 13.5% during the third quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate’s stock worth $84,000 after purchasing an additional 29 shares during the period. Finally, Seamount Financial Group Inc. raised its holdings in shares of UnitedHealth Group by 4.7% during the second quarter. Seamount Financial Group Inc. now owns 818 shares of the healthcare conglomerate’s stock valued at $255,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a report on Wednesday, October 29th. TD Cowen upped their target price on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. Barclays raised their price objective on shares of UnitedHealth Group from $386.00 to $391.00 and gave the company an “overweight” rating in a research report on Monday, January 5th. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday. Finally, Jefferies Financial Group cut their target price on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $380.67.

UnitedHealth Group Stock Down 0.6%

Shares of UNH stock opened at $292.20 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36. The stock has a market cap of $264.69 billion, a P/E ratio of 22.15, a price-to-earnings-growth ratio of 1.75 and a beta of 0.42. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82. The stock has a fifty day moving average price of $331.39 and a 200 day moving average price of $323.38.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. During the same period last year, the business earned $6.81 earnings per share. The business’s revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s payout ratio is currently 67.02%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q4 EPS slightly beat expectations and the stock rallied on the earnings/earnings?beat narrative, supporting a short-term bounce. UnitedHealth Group Shares Up After Earnings Beat
• Positive Sentiment: Market commentary highlighted a better 2026 cost outlook and attention from healthcare ETFs, which likely amplified the intraday recovery. Healthcare ETFs in Focus as UnitedHealth Rises
• Positive Sentiment: Several sell?side analysts trimmed price targets modestly but kept Overweight/Buy/Outperform ratings, indicating continued institutional support despite cuts. (Morgan Stanley trim to $409 noted). Morgan Stanley Modest Target Cut
• Neutral Sentiment: Analyst views are mixed: some argue UNH is undervalued on a longer-term DCF/FCF basis, while others warn regulatory and political risk could keep multiples depressed until clarity on Medicare/MA reimbursement emerges. Seeking Alpha Valuation View
• Neutral Sentiment: Multiple brokerages cut price targets (Jefferies, Leerink, Oppenheimer, RBC, UBS among others) but many retained buy ratings — a signal that expectations are being reset rather than consensus conviction collapsing. Analyst Price Target Moves
• Negative Sentiment: Unusual bearish options activity: traders bought roughly 376,697 put contracts (about +131% vs. average), suggesting many investors are hedging or betting on further downside.
• Negative Sentiment: Regulatory pressure — notably lower Medicare Advantage reimbursement guidance and a “CMS rate shock” — drove a sharp multi?day selloff (near?20% intraday plunge earlier) and large market?cap loss, weighing on sentiment. InsiderMonkey: UNH Loses 19.6%
• Negative Sentiment: Reports of politically timed stock sales by some lawmakers and the magnitude of the recent market cap decline have amplified reputational and headline risk, keeping volatility elevated. Fool: UNH Plunges After Weak Earnings

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.